Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

by L.Y. Dirix, P.A. Van Dam, A.M. Prove, P.B. Vermeulen
Published 2010-09-01

A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer

by C. Van Berckelaer, M. Van Geyt, S. Linders, C. Rypens, X.B. Trinh, W.A.A. Tjalma, S. Van Laere, C. Colpaert, L. Dirix, P.A. van Dam
Published 2020-10-01